Relaxin-3 receptor (RXFP3) activation in the nucleus of the solitary tract modulates respiratory rate and the arterial chemoreceptor reflex in rat

WI Furuya; RR Dhingra; AL Gundlach; MA Hossain; M Dutschmann

Journal article

Relaxin-3 receptor (RXFP3) activation in the nucleus of the solitary tract modulates respiratory rate and the arterial chemoreceptor reflex in rat

WI Furuya, RR Dhingra, AL Gundlach, MA Hossain, M Dutschmann

Respiratory Physiology and Neurobiology | ELSEVIER | Published : 2020

DOI: 10.1016/j.resp.2019.103310

Abstract

The neuropeptide relaxin-3 is expressed by the pontine nucleus incertus. Relaxin-3 and synthetic agonist peptides modulate arousal and cognitive processes via activation of the relaxin-family peptide 3 receptor (RXFP3). Despite the presence of RXFP3 in the nucleus of the solitary tract (NTS), the ability of RXFP3 to modulate NTS-mediated cardiorespiratory functions has not been explored. Therefore, we examined the effects of bilateral microinjections of the selective agonist, RXFP3-A2 (40 μM, 100 nL/side), into the NTS in perfused working-heart-brainstem-preparations from rats (n = 6), while recording phrenic, vagal, and thoracic sympathetic chain activity (PNA, VNA, t-SCA) and heart rate (H..

View full abstract

University of Melbourne Researchers

Akhter Hossain Author

Related Projects (3)

Enhancing the clinical potential of relaxin

The hormone relaxin mediates cardiovascular and kidney changes during pregnancy. These important functions have led to its current use in cl..

Learning to breathe: emerging inhibition of sensory relay mechanisms.

This project aims to investigate the maturation of the respiratory network from a functional to synaptic level. The brain generates motor co..

Novel insulin to treat diabetes

The glucose regulatory hormone, insulin, remains the only treatment for type I diabetes and up to 30% of type II diabetes, both of which are..

Grants

Awarded by Institute of Neurosciences, Mental Health and Addiction

Funding Acknowledgements

This study was supported by an Australian Research Council (ARC) Future Fellowship to MD and ARC Discovery Grant (DP170104861) to MD. Peptide chemistry was partially supported by NHMRC (Australia) project grants (1023321 and 1023078) to MAH.We acknowledge financial support from the Victorian State Government Infrastructure Program to The Florey Institute of Neuroscience and Mental Health.